17 results on '"Buslei, Rolf"'
Search Results
2. Pituicytoma-An outlook on possible targeted therapies
3. Preclinical transgenic and patient-derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngioma
4. Models of human adamantinomatous craniopharyngioma tissue: Steps toward an effective adjuvant treatment
5. IgG4-related hypophysitis is highly prevalent among cases of histologically confirmed hypophysitis
6. BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts
7. Activation and regulation of endogenous retroviral genes in the human pituitary gland and related endocrine tumours
8. Melanotic Tumors of the Nervous System are Characterized by Distinct Mutational, Chromosomal and Epigenomic Profiles
9. Insights into the Infiltrative Behavior of Adamantinomatous Craniopharyngioma in a New Xenotransplant Mouse Model
10. Comparative study of soft tissue perineurioma and meningioma using a five‐marker immunohistochemical panel
11. Target Gene Activation of the Wnt Signaling Pathway in Nuclear β-Catenin Accumulating Cells of Adamantinomatous Craniopharyngiomas
12. SpontaneousIn VitroTransformation of Adult Neural Precursors into Stem-Like Cancer Cells
13. In vitro and ex vivo evaluation of second‐generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy
14. Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo
15. Abnormalities of prefrontal cortex SNARE complex proteins in bipolar disorder
16. Allele-specific losses of heterozygosity on chromosomes 1 and 17 revealed by whole genome scan of ethylnitrosourea-induced gliomas of BDIX � BDIV hybrid rats
17. Allele-specific losses of heterozygosity on chromosomes 1 and 17 revealed by whole genome scan of ethylnitrosourea-induced BDIX�BDIV hybrid rat gliomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.